Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1995 | 03-1995 | 12-1994 | 09-1994 | 06-1994 | |
| Sales | 651 | 495 | 1,590 | 222 | 302 |
| Cost of Goods | -1,167 | 0 | 1,137 | 1,150 | 978 |
| Gross Profit | 495 | 453 | 339 | 339 | 267 |
| Operating Expenses | -532 | 640 | 698 | 577 | 1,972 |
| Operating Income | 2,183 | -145 | -108 | -1,355 | -1,670 |
| Interest Expense | -49 | 32 | 9 | 8 | 9 |
| Other Income | -2,426 | -84 | 13 | 1,279 | 1,529 |
| Pre-tax Income | -194 | -261 | -104 | -84 | -151 |
| Income Tax | -9 | 6 | 19 | 5 | 8 |
| Net Income Continuous | 13 | -253 | -161 | -190 | -150 |
| Net Income Discontinuous | 0 | 2,525 | 0 | 59 | 0 |
| Net Income | $13 | $2,272 | $-161 | $-131 | $-150 |
| EPS Basic Total Ops | 0.00 | 0.39 | -0.03 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | 0.00 | -0.04 | -0.03 | -0.03 | -0.03 |
| EPS Basic Discontinuous Ops | N/A | 0.43 | N/A | 0.01 | N/A |
| EPS Diluted Total Ops | 0.00 | 0.39 | -0.03 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | 0.00 | -0.04 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Discontinuous Ops | N/A | 0.43 | N/A | 0.01 | N/A |
| EBITDA(a) | $2,183 | $-145 | $-108 | $-1,355 | $-1,670 |